Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKesson
Merck
Medtronic
AstraZeneca

Last Updated: October 6, 2022

Patent: 5,605,690


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 5,605,690
Title: Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor
Abstract:A method for treating TNF-dependent inflammatory diseases in a mammal by administering a TNF antagonist, such as soluble TNFR.
Inventor(s): Jacobs; Cindy A. (Seattle, WA), Smith; Craig A. (Seattle, WA)
Assignee: Immunex Corporation (Seattle, WA)
Application Number:08/385,229
Patent Claims:see list of patent claims

Details for Patent 5,605,690

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 11/02/1998 See Plans and Pricing 2014-02-25
Immunex Corporation ENBREL etanercept For Injection 103795 05/27/1999 See Plans and Pricing 2014-02-25
Immunex Corporation ENBREL etanercept Injection 103795 09/27/2004 See Plans and Pricing 2014-02-25
Immunex Corporation ENBREL etanercept Injection 103795 02/01/2007 See Plans and Pricing 2014-02-25
Immunex Corporation ENBREL MINI etanercept Injection 103795 09/14/2017 See Plans and Pricing 2014-02-25
Immunex Corporation ENBREL etanercept Injection 103795 See Plans and Pricing 2014-02-25
Immunex Corporation ENBREL etanercept Injection 103795 03/05/2020 See Plans and Pricing 2014-02-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 5,605,690

Country Patent Number Estimated Expiration
South Africa 907072 See Plans and Pricing
World Intellectual Property Organization (WIPO) 9406476 See Plans and Pricing
World Intellectual Property Organization (WIPO) 9319777 See Plans and Pricing
World Intellectual Property Organization (WIPO) 9103553 See Plans and Pricing
United States of America RE36755 See Plans and Pricing
United States of America 7459528 See Plans and Pricing
United States of America 7057022 See Plans and Pricing
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
AstraZeneca
Medtronic
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.